On Monday, Robert F. Kennedy Jr. disclosed plans to establish a clinic on the National Institutes of Health campus in Bethesda, Maryland, aimed at investigating and caring for individuals who may have experienced vaccine-related injuries. The proposal also calls for compensating physicians who submit reports of suspected injuries and seeks to update the federal mechanism that monitors post-vaccination adverse events. Bloomberg News noted that information on the clinic’s funding, criteria for patient inclusion, research methodology, and supervisory arrangements has not been made public. Representatives from HHS and NIH declined to comment when approached.
Kennedy’s Push for a Federal Vaccine Injury Clinic
The issue carries concrete implications for families and medical professionals. Parents deciding on standard immunizations, clinicians who document side effects, and individuals who claim to have been injured all depend on vaccine-safety studies that are open and verifiable. Kennedy presented the effort as a reaction to families who feel their worries have been dismissed. Addressing attendees of a Children’s Health Defense gathering, he stated, “For many years, you’ve asked questions from outside the government, as I did,” and noted that his position heading the department enables him to allocate federal resources toward answering those inquiries. Kennedy formerly served as the head of Children’s Health Defense, an organization opposed to vaccines.
The NIH gathering featured NIH Director Jay Bhattacharya, CDC Director Erica Schwartz, CMS Administrator Mehmet Oz, and acting FDA Commissioner Kyle Diamantas, according to Bloomberg. A discussion panel also included parents who assert that vaccines have injured their children. The trade journal Pink Sheet characterized the location as a clinic dedicated to observational research on vaccine injuries and noted that the National Institute of Allergy and Infectious Diseases is weighing participation in studies of vaccination schedules. In the MAHA strategy issued in September 2025, HHS identified “vaccine injury” as one of its research priorities.
Uncertainties Over the Clinic’s Methods and Funding
Observational studies track individuals without allocating specific interventions, allowing researchers to record symptoms and trends but typically lacking the ability to prove causation between a vaccine and a health condition. The usefulness of the proposed clinic will hinge on undisclosed elements such as whether control groups are employed, how diagnoses are validated, and whether findings undergo independent peer review. Additional uncertainties involve the clinic’s yearly financing, source of funds, anticipated patient enrollment, clinical eligibility standards, and the extent to which data will be made publicly accessible. The mechanics and expense of the suggested physician-compensation program for reporting suspected injuries also remain unclear.
This strategy contrasts with long-standing federal vaccine-safety mechanisms. The Vaccine Adverse Event Reporting System, jointly administered by the CDC and FDA, collects submissions from patients, relatives, health-care workers and manufacturers. The CDC warns that “a report to VAERS does not mean that a vaccine caused an adverse event.” The Vaccine Safety Datalink, launched in 1990, is a partnership of the CDC with 13 sites that reviews electronic health-record data each week to detect uncommon or severe post-vaccination issues. The National Vaccine Injury Compensation Program is “a no-fault alternative to the traditional legal system for resolving vaccine injury petitions,” with claims filed at the U.S. Court of Federal Claims.
Anyone who suspects a reaction after a shot can talk with a clinician and file a VAERS report, which any patient or family member may submit. People who believe they were seriously injured can learn about the compensation program through HRSA. Trouble breathing, swelling of the face or throat, or a rapidly worsening condition after any vaccine needs emergency care.
